Notice: This company has been marked as potentially delisted and may not be actively trading. GenMark Diagnostics (GNMK) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Carlsmed Adds Industry Veteran, Kevin O’Boyle, to Board of DirectorsOctober 8, 2024 | finance.yahoo.comQuest Diagnostics Incorporated (DGX)March 15, 2024 | finance.yahoo.comYouTube star Grace Helbig shares breast cancer diagnosisJuly 8, 2023 | nbcnews.comStudy finds brain 'signature' for chronic pain, which could improve diagnosis, treatmentJune 6, 2023 | usatoday.comGenmark Diagnos Share ChatJune 2, 2023 | lse.co.ukWhen autism isn't diagnosed until adulthood: 'It takes a mental crisis to get diagnosed'May 28, 2023 | usatoday.comDoctor who helped broaden autism spectrum ‘very sorry’ for over-diagnosisApril 29, 2023 | nypost.comWith 11.1% CAGR, Molecular Diagnostics Market to Surpass US$ 37.19 Bn by 2028 - Global Analysis by TMRApril 27, 2023 | benzinga.comBruce Willis’ family reveals ‘cruel’ dementia diagnosisFebruary 23, 2023 | nypost.comWhat is frontotemporal dementia? Bruce Willis' diagnosis, explainedFebruary 18, 2023 | cbsnews.comCelebrities react to Bruce Willis' frontotemporal dementia diagnosisFebruary 18, 2023 | cbsnews.comHepatitis B and C diagnostics market size to increase by USD 2,055.79 million; North America to account for 47% of market growth - TechnavioJanuary 26, 2023 | finance.yahoo.comChristina Applegate says she’s nervous about first awards show since MS diagnosisJanuary 17, 2023 | nypost.comGravity Diagnostics Appoints Karen Hargett as Chief People OfficerJanuary 10, 2023 | finance.yahoo.comInfectious Disease Diagnostics Global Market Report 2022: Increasing Availability and Affordability of Rapid Diagnostic Kits Presents OpportunitiesDecember 31, 2022 | finance.yahoo.comMolecular Diagnostics Market is Booming and Expected to Reach USD 37.19 Billion to 2028, notes TMR StudyOctober 30, 2022 | finance.yahoo.comGena Tew Reveals Whether She's Able To Have Children After AIDS DiagnosisOctober 16, 2022 | newsweek.comBoston Heart Diagnostics Launches LipoMap™: One of the Most Comprehensive Assessments of Lipid Metabolism AvailableOctober 5, 2022 | finance.yahoo.comGenMark Diagnostics, Inc. NewsJuly 30, 2022 | thestreet.comSpecific Diagnostics announces that Nathan Clark, former GenMark Sales Leader, joins Specific Diagnostics as Strategic Account Director, US EastMay 6, 2022 | benzinga.com Get GenMark Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for GNMK and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover GNMK Media Mentions By Week GNMK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNMK News Sentiment▼0.000.61▲Average Medical News Sentiment GNMK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNMK Articles This Week▼00▲GNMK Articles Average Week Get GenMark Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for GNMK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Merit Medical Systems News Today Inspire Medical Systems News Today PROCEPT BioRobotics News Today Haemonetics News Today ICU Medical News Today Axonics News Today NovoCure News Today Inari Medical News Today iRhythm Technologies News Today Tandem Diabetes Care News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNMK) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GenMark Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GenMark Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
